Korean Traditional Medicines as Novel Drugs for Neuropsychiatric Disorders.
- Author:
Sung Kil MIN
1
;
Chang Hyung HONG
Author Information
1. Department of Psychiatry, Institution of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, Korea. skmin518@yumc.yonsei.ac.kr
- Publication Type:Original Article
- Keywords:
Korean traditional medicine;
New drug;
Neuropsychiatric disorders
- MeSH:
Antidepressive Agents;
Antipsychotic Agents;
Biological Products;
Natural Resources;
Cooperative Behavior;
Investments;
Korea;
Medicine, Korean Traditional;
Medicine, Traditional;
Nanotechnology;
Nootropic Agents;
Pharmacognosy;
Pharmacology;
Pharmacy;
Schools, Medical
- From:Korean Journal of Psychopharmacology
2007;18(1):5-17
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
This paper reviews history of new drug development in Korea as well as researchs on development of new psychotherapeutic drug from traditional medicines or natural products in Korea. Korea has a long history of traditional medicine and accumulated knowledge of natural resources. However, only a few new drug have been developed from those natural products. Now many researchers in Korea are devoting themselves to test the possibility of natural products as antipsychotic drugs, antidepressants, anxiolytic drugs and cognitive enhancers. However, only a few graduates from traditional medical schools in Korea are engaging in research on developing new drug from natural products and they are not familiar to research methods of western medicine and pharmacology. For research and development of new drug from natural products or traditional medicines, many researchers should be trained for methodology of basic medicine, pharmacology, pharmacognosy, and oriential pharmacy. Government and pharmaceutical companies need to provide more investment for R & D for new drug from natural products including establishment of data base for component of traditional medicines and natural products, system development integrating information technology, bio-technology and nanotechnology, and international collaboration with advanced countries which have common interest in new drug development from natural products.
